Pantoprazole Teva

Pantoprazole, the active ingredient in Pantoprazole Teva, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Pantoprazole Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazole Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors. - Helicobacter pylori eradication regimens (as part of combination therapy): enhances eradication rates when used with antibiotics. - NSA‑induced ulcer prophylaxis: lowers the risk of ulcer development in patients requiring long‑term NSAID therapy.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea or abdominal discomfort: occasional. - Flatulence: mild bloating. - Constipation: occasional. - Dry mouth: mild.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile‑associated colitis: may present with persistent diarrhea. - Low magnesium levels (hypomagnesemia): can cause muscle cramps or arrhythmias. - Bone fractures (with long‑term use): increased risk of hip, wrist or spine fractures. - Liver enzyme elevations: may indicate hepatic stress. - Acute interstitial nephritis: rare kidney inflammation.

When using Pantoprazole, consider the following precautions: - Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Monitor long‑term therapy: evaluate need for continued treatment after 12 months. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Elderly patients: start with the lowest effective dose and monitor for fractures. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption and efficacy. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations.

Moderate Interactions (Monitor Closely): - Antiplatelet drug clopidogrel: possible reduction in antiplatelet effect. - Warfarin: may increase INR and bleeding risk. - Methotrexate (high dose): reduced renal clearance leading to toxicity. - Digoxin: increased serum levels. - Iron supplements: decreased absorption; separate dosing by at least 2 hours.